| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
NADRA is a Pakistani government organization that provides solutions for identification, e-governance, and secure documents.
Ser Imaging Inc is a Irving, TX-based company in the Software & Internet sector.
Adrich is a company that provides IoT connected product eCommerce technology, allowing brands to gain real consumer usage insights and re-orders through smart sensing labels and customized software.
Monolith AI is a company that provides AI software for engineering product development, allowing engineers to build self-learning models to predict design performance, test less, learn more, and develop better quality products faster.